Which Is The Best Bet? NorthStar Asset Management Group Inc (NSAM), Navistar International Corp (NAV) and Ampio Pharmaceuticals Inc(AMPE)

Posted by Saimoon April 6, 2015 0 Comment 578 views


New York, NY – GDP INSIDER  –  04/06/2015.

This article discusses three companies: NorthStar Asset Management Group Inc (NYSE:NSAM), Navistar International Corp (NYSE:NAV) and Ampio Pharmaceuticals Inc(NYSEMKT:AMPE)

NorthStar Asset Management Group Inc (NYSE:NSAM) saw a minuscule decline of 0.92% or $0.22 during its last trading session to finish the day at a closing price of $23.78 on high trading volume of 1.51 million compared to its three month average trading volume of 0.923 million, after an insider, Daniel R. Gilbert, sold 550.000 of company’s shares at an average price of $23.84, for a total transaction of $13,112, 000. With EPS of $0.08, strong quarterly revenue growth (yoy) of 469.90% and quarterly earnings growth (yoy) of 3477.30%, NorthStar Asset Management Group Inc has a long term upside potential and a solid buy.

Does NorthStar Asset Management Group Inc Have The Fundamental Support For More Gains? Read Our Free NSAM Analysis To Know More.

Navistar International Corp (NYSE:NAV) continued its downward trend with the stock closing down 0.69% after losing twenty cents to finish the day at $28.61 on high trading volume of 1.308 million, compared to its three month average trading volume of 0.901 million. Over the past one week and over the past four weeks, the shares of Navistar International Corp have declined 0.80% and 0.42%, respectively. The stock has also been underperforming the S&P 500 since the beginning of the year, with the stock down 14.55% year to date, compared to the index which is up 0.39% over the same period, making it a hold for now.

Does Navistar International Corp Have The Fundamentals To Bounce Back? Take A Closer Look With Free NAV Investment Analysis.

Ampio Pharmaceuticals Inc(NYSEMKT:AMPE) continued to post strong gains on Thursday closing up 3.56% or $0.27 at $7.85, on light trading of 0.357 million shares compared to its three month average trading volume of 0.825 million. The stock has been vastly outperforming the S&P 500 so far this year, posting a gain of 128.86% year to date compared to the S&P 500 which is currently up only 0.39% for the same period. With RSI now at 60.27 the stock may be slightly overvalued and could correct downwards making it a hold rather than buy for now.
Are Ampio Pharmaceuticals Inc’s Shares OverValued? Get Our Free AMPE Analysis To Know More.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.


Write Your Comment